日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop

生物标志物驱动的过敏性疾病和哮喘药物研发:FDA公开研讨会

Rabin, Ronald L; Altman, Matthew C; Arshad, S Hasan; Beger, Richard D; Frischmeyer-Guerrerio, Pamela A; Goleva, Elena; Hamilton, Robert G; Khurana Hershey, Gurjit K; Shamji, Mohamed H; Sampson, Hugh A; Santos, Alexandra F; Shreffler, Wayne G; Togias, Alkis; Vieths, Stefan; Wambre, Erik; Wenzel, Sally E; Hise, Kathleen; Lee, Joohee; Tripathi, Anubha; Slater, Jay E

The Potential of Human Monoclonal IgE Antibodies to Establish Biological Potency and Stability of Allergen Extracts

人单克隆IgE抗体在确定过敏原提取物的生物活性和稳定性方面的潜力

Rabin, Ronald L

Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination

评估抗PEG抗体与mRNA COVID-19疫苗接种后过敏反应的关联性

Zhou, Zhao-Hua; Cortese, Margaret M; Fang, Jia-Long; Wood, Robert; Hummell, Donna S; Risma, Kimberly A; Norton, Allison E; KuKuruga, Mark; Kirshner, Susan; Rabin, Ronald L; Agarabi, Cyrus; Staat, Mary A; Halasa, Natasha; Ware, Russell E; Stahl, Anna; McMahon, Maureen; Browning, Peter; Maniatis, Panagiotis; Bolcen, Shanna; Edwards, Kathryn M; Su, John R; Dharmarajan, Sai; Forshee, Richard; Broder, Karen R; Anderson, Steven; Kozlowski, Steven

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines

欧洲过敏与临床免疫学会 (EAACI) 关于 COVID-19 疫苗严重过敏反应的诊断、管理和预防的声明

Sokolowska, Milena; Eiwegger, Thomas; Ollert, Markus; Torres, Maria J; Barber, Domingo; Del Giacco, Stefano; Jutel, Marek; Nadeau, Kari C; Palomares, Oscar; Rabin, Ronald L; Riggioni, Carmen; Vieths, Stefan; Agache, Ioana; Shamji, Mohamed H

Racial/ethnic differences in eligibility for asthma biologics among pediatric populations

儿童哮喘生物制剂治疗资格的种族/民族差异

Wohlford, Eric M; Huang, Peter F; Elhawary, Jennifer R; Millette, Lauren A; Contreras, Maria G; Witonsky, Jonathan; Holweg, Cécile T J; Oh, Sam S; Lee, Christine; Merenda, Christine; Rabin, Ronald L; Araojo, Richardae; Mak, Angel C Y; Eng, Celeste S; Hu, Donglei; Huntsman, Scott; LeNoir, Michael A; Rodríguez-Santana, Jose R; Borrell, Luisa N; Burchard, Esteban G

Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus

人类新生儿髓系树突状细胞对人类呼吸道合胞病毒缺乏激活标志物诱导和趋化因子受体转换

Le Nouën, Cyril; Hillyer, Philippa; Levenson, Eric; Martens, Craig; Rabin, Ronald L; Collins, Peter L; Buchholz, Ursula J

Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control

人类呼吸道上皮细胞系对呼吸道合胞病毒的不同反应反映了不同的感染控制模式

Hillyer, Philippa; Shepard, Rachel; Uehling, Megan; Krenz, Mina; Sheikh, Faruk; Thayer, Kalyn R; Huang, Lei; Yan, Lihan; Panda, Debasis; Luongo, Cindy; Buchholz, Ursula J; Collins, Peter L; Donnelly, Raymond P; Rabin, Ronald L

Early treatment with reverse transcriptase inhibitors significantly suppresses peak plasma IFNα in vivo during acute simian immunodeficiency virus infection

在急性猴免疫缺陷病毒感染期间,早期使用逆转录酶抑制剂治疗可显著抑制体内血浆中IFNα的峰值。

George, Jeffy; Renn, Lynnsey; Verthelyi, Daniela; Roederer, Mario; Rabin, Ronald L; Mattapallil, Joseph J

Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells

埃博拉病毒VP35和VP24蛋白对人类树突状细胞整体基因表达的不同时间效应

Ilinykh, Philipp A; Lubaki, Ndongala M; Widen, Steven G; Renn, Lynnsey A; Theisen, Terence C; Rabin, Ronald L; Wood, Thomas G; Bukreyev, Alexander

Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activation

人偏肺病毒的SH和G糖蛋白抑制巨胞饮作用介导的病毒进入人树突状细胞,并降低CD4+ T细胞的活化。

Le Nouën, Cyril; Hillyer, Philippa; Brock, Linda G; Winter, Christine C; Rabin, Ronald L; Collins, Peter L; Buchholz, Ursula J